GMP Audit for Materials Management: From Receipt to Release

GMP audit materials management

What Materials Management Audits Cover

Materials management is the system that controls the receipt, storage, sampling, testing, and release of materials used in manufacturing. It is the first line of defense against contamination and mix ups. If materials are not controlled, the product cannot be assured.

A GMP audit for materials management assesses whether materials are received and identified correctly, whether they are stored appropriately, whether sampling and testing are performed, and whether release is controlled. The scope includes receipt, quarantine, storage, sampling, testing, release, and rejection.

The Regulatory Context

FDA 21 CFR 211 Subpart E

The FDA sets requirements for control of components in 21 CFR 211 Subpart E. Materials must be received, identified, stored, sampled, tested, and released.

EU GMP Chapter 4 and Chapter 5

Chapter 4 of EudraLex Volume 4 covers documentation. Chapter 5 covers production, including materials management.

ICH Q7 and Materials Management

ICH Q7 covers materials management for APIs, including receipt, quarantine, sampling, and release.

PIC/S and WHO

PIC/S Guide PE 009 and WHO GMP guidelines cover materials management.

What Audits Focus On

Receipt

Materials should be received and identified. The audit should check that receipt is documented and that materials are checked against specifications.

Quarantine

Materials should be quarantined until released. The audit should check that quarantine is controlled.

Storage

Materials should be stored appropriately. The audit should check that storage conditions are maintained.

Sampling

Sampling should be representative. The audit should check that sampling is documented and controlled.

Testing

Testing should be performed. The audit should check that testing is completed and documented.

Release

Release should be controlled. The audit should check that release is authorized and documented.

Rejection

Rejected materials should be controlled. The audit should check that rejection is documented and that materials are segregated.

Common Findings in Materials Management Audits

Receipt Documentation Gaps

Quarantine Controls That Are Not Followed

Storage Conditions That Are Not Maintained

Sampling That Is Not Representative

Release That Is Not Authorized

Rejection That Is Not Controlled

Introducing GxP Cellators for Materials Management Audits

GxP Cellators provides GMP audits for materials management covering receipt, quarantine, storage, sampling, testing, release, and rejection.

We work across FDA, EMA, Health Canada, MHRA, WHO, and PIC/S frameworks. Our auditors bring regulatory inspection and industry quality experience, and we deliver clear, prioritized reports with practical remediation guidance.

Control Your Materials

Visit https://www.gxpcellators.com/gmp-auditing/ for service details. Email or use https://www.gxpcellators.com/contact/ to discuss your materials management audit.

Frequently Asked Questions About Materials Management Audits

Why is quarantine important?

Quarantine prevents unreleased materials from being used in production.

How should sampling be performed?

Sampling should be representative and should follow a defined plan.

What is release?

Release is the authorization to use a material in production.

Can you help us prepare for an inspection of materials management?

Yes. We conduct readiness reviews and mock inspections.

How do I request a materials management audit?

Email or use https://www.gxpcellators.com/contact/. Service details are at https://www.gxpcellators.com/gmp-auditing/.

You cannot copy content of this page

Verified by MonsterInsights